Rhythm Pharmaceuticals, Inc. (RYTM) Discusses FDA Approval of IMCIVREE for Acquired Hypothalamic Obesity Transcript
RhythmRhythm(US:RYTM) Seeking Alpha·2026-03-20 15:32

公司电话会议 - 公司为Rhythm Pharmaceuticals，正在举行电话会议 [1] - 会议由投资者关系部门的David Connolly主持 [1]

Rhythm Pharmaceuticals, Inc. (RYTM) Discusses FDA Approval of IMCIVREE for Acquired Hypothalamic Obesity Transcript - Reportify